Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 210 of 1,261
  1. US 11576982

    Nipah virus envelope pseudotyped lentiviruses and methods of their use

    The Regents of the University of California · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  2. US 11578103

    Nucleic acids encoding Zika virus-like particles and their use in Zika virus vaccines and diagnostic assays

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  3. US 11576924

    Compounds for the prevention and treatment of diseases and the use thereof

    Galectin Sciences, LLC · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  4. US 11576889

    Methods of identifying and treating patients with HIF-2 inhibitor resistance

    The Board of Regents of the University of Texas System · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  5. US 11578338

    Hemipteran active insecticidal protein

    CORTEVA AGRISCIENCE LLC · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  6. US 11576948

    Long-acting VEGF inhibitors for intraocular neovascularization

    The Regents of the University of California · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  7. US 11576971

    Method of filling a container with no headspace

    Coherus BioSciences, Inc. · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  8. US 11576907

    Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  9. US 11576983

    Treatments for retinal disease

    4D MOLECULAR THERAPEUTICS INC. · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  10. US 11578127

    Anti-Fc epsilon-R1 alpha (FcεR1α) antibodies, bispecific antigen-binding molecules that bind FcεR1α and CD3, and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  11. US 11578062

    Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide

    Vertex Pharmaceuticals Incorporated · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  12. US 11576863

    Formulation of an antibody and use thereof

    Takeda Pharmaceutical Company Limited · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  13. US 11576922

    CD73 inhibitors

    ORIC PHARMACEUTICALS, INC. · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  14. US 11578313

    CRISPR-Cas effector polypeptides and methods of use thereof

    The Regents of the University of California · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  15. US 11578126

    Chimeric antigen receptor (CAR) comprising a CD19-binding domain

    AUTOLUS LIMITED · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  16. US 11576356

    Genetically modified non-human animals and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  17. US 11578078

    Heterocyclic RIP1 inhibitory compounds

    Rigel Pharmaceuticals, Inc. · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  18. US 2023040008

    ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES

    BRACCO IMAGING SPA [IT] · Granted Feb 9, 2023 · Expires Feb 4, 2043

    granted
  19. EP 4125971

    BAKTERIENSTÄMME, ZUSAMMENSETZUNGEN DAVON UND VERWENDUNG DAVON IN EINEM VERFAHREN ZUR BEHANDLUNG VON VITAMIN-D-MANGEL UND DAMIT ASSOZIIERTEN ERKRANKUNGEN

    SOFAR SPA [IT] · Granted Feb 8, 2023 · Expires Feb 3, 2043

    granted
  20. US 11571485

    Peptides and antibodies for detecting changes in alzheimer's disease brain and methods of use thereof

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  21. US 11572591

    Methods and assays for subtyping Staphylococcus aureus clonal complex 8 strains

    Arizona Board of Regents on Behalf of Northern Arizona University · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  22. US 11572575

    Compositions for transfecting resistant cell types

    Precision Nanosystems ULC · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  23. US 11572588

    Methods of evaluating treatment efficacy and/or treatment duration in mycobacterial diseases

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  24. US 11572364

    Pteridinone compounds and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.